Sign in
4

Changes in Ownership

Amphastar Pharmaceuticals, Inc. Filed Acc 0001104659-20-012712

President and General Counsel sold 44,401 shares at an average $19.75 ($876,765)

  • President and General Counsel acquired 44,401 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Shandell Jason B. President and General Counsel 2020-02-05 Option exercise +15,615 $14.40 $224,856 154,513 D
Shandell Jason B. President and General Counsel 2020-02-05 Sale −15,615 $19.57 $305,554 138,898 D
Shandell Jason B. President and General Counsel 2020-02-06 Option exercise +21,933 $14.40 $315,835 160,831 D
Shandell Jason B. President and General Counsel 2020-02-06 Sale −21,933 $19.83 $434,951 138,898 D
Shandell Jason B. President and General Counsel 2020-02-07 Option exercise +6,853 $14.40 $98,683 145,751 D
Shandell Jason B. President and General Counsel 2020-02-07 Sale −6,853 $19.88 $136,260 138,898 D
Derivatives
Shandell Jason B. President and General Counsel 2020-02-05 Option exercise · Employee Stock Option (right to buy) −15,615 75,730 D
Shandell Jason B. President and General Counsel 2020-02-06 Option exercise · Employee Stock Option (right to buy) −21,933 53,797 D
Shandell Jason B. President and General Counsel 2020-02-07 Option exercise · Employee Stock Option (right to buy) −6,853 46,944 D
Open-market sales · 44,401 sh · avg $19.75 · $876,765
Loading xslF345X03/a4.xml…